6401. Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
作者: Ethan Basch.;Deborah Schrag.;Sydney Henson.;Jennifer Jansen.;Brenda Ginos.;Angela M Stover.;Philip Carr.;Patricia A Spears.;Mattias Jonsson.;Allison M Deal.;Antonia V Bennett.;Gita Thanarajasingam.;Lauren J Rogak.;Bryce B Reeve.;Claire Snyder.;Deborah Bruner.;David Cella.;Lisa A Kottschade.;Jane Perlmutter.;Cindy Geoghegan.;Cleo A Samuel-Ryals.;Barbara Given.;Gina L Mazza.;Robert Miller.;Jon F Strasser.;Dylan M Zylla.;Anna Weiss.;Victoria S Blinder.;Amylou C Dueck.
来源: JAMA. 2022年327卷24期2413-2422页
Electronic systems that facilitate patient-reported outcome (PRO) surveys for patients with cancer may detect symptoms early and prompt clinicians to intervene.
6403. Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity.
作者: Ali Aminian.;Rickesha Wilson.;Abbas Al-Kurd.;Chao Tu.;Alex Milinovich.;Matthew Kroh.;Raul J Rosenthal.;Stacy A Brethauer.;Philip R Schauer.;Michael W Kattan.;Justin C Brown.;Nathan A Berger.;Jame Abraham.;Steven E Nissen.
来源: JAMA. 2022年327卷24期2423-2433页
Obesity increases the incidence and mortality from some types of cancer, but it remains uncertain whether intentional weight loss can decrease this risk.
6405. Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
作者: Caroline G Tai.;Lisa L Maragakis.;Sarah Connolly.;John DiFiori.;Deverick J Anderson.;Yonatan H Grad.;Christina DeFilippo Mack.
来源: JAMA. 2022年328卷2期209-211页
This study compares the incidence of SARS-CoV-2 infection in players and staff of the National Basketball Association (NBA) who did vs those who did not receive a COVID-19 vaccine booster dose.
6416. Screening for Impaired Visual Acuity in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
作者: Roger Chou.;Christina Bougatsos.;Rebecca Jungbauer.;Sara Grusing.;Ian Blazina.;Shelley Selph.;Daniel E Jonas.;Shandiz Tehrani.
来源: JAMA. 2022年327卷21期2129-2140页
A 2016 review for the US Preventive Services Task Force (USPSTF) found that effective treatments are available for refractive errors, cataracts, and wet (advanced neovascular) or dry (atrophic) age-related macular degeneration (AMD), but there were no differences between visual screening vs no screening on visual acuity or other outcomes.
6417. Screening for Impaired Visual Acuity in Older Adults: US Preventive Services Task Force Recommendation Statement.
作者: .;Carol M Mangione.;Michael J Barry.;Wanda K Nicholson.;Michael Cabana.;David Chelmow.;Tumaini Rucker Coker.;Esa M Davis.;Katrina E Donahue.;John W Epling.;Carlos Roberto Jaén.;Alex H Krist.;Martha Kubik.;Li Li.;Gbenga Ogedegbe.;Lori Pbert.;John M Ruiz.;Melissa A Simon.;James Stevermer.;John B Wong.
来源: JAMA. 2022年327卷21期2123-2128页
Impairment of visual acuity is a serious public health problem in older adults. The number of persons 60 years or older with impaired visual acuity (defined as best corrected visual acuity worse than 20/40 but better than 20/200) was estimated at 2.91 million in 2015, and the number who are blind (defined as best corrected visual acuity of 20/200 or worse) was estimated at 760 000. Impaired visual acuity is consistently associated with decreased quality of life in older persons, including reduced ability to perform activities of daily living, work, and drive safely, as well as increased risk of falls and other unintentional injuries.
|